VistaGen Therapeutics Inc.
03/18/2026 | Press release | Distributed by Public on 03/18/2026 14:46
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.
On March 17, 2026, Mary Rotunno resigned from the Board of Directors of Vistagen Therapeutics, Inc., effective April 1, 2026.
VistaGen Therapeutics Inc. published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 18, 2026 at 20:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]